Lavo Life Sciences offers a cutting-edge AI platform designed to predict the crystal structures of small molecule pharmaceuticals.
By leveraging advanced machine learning algorithms, Lavo’s technology accelerates the identification of stable and effective drug formulations, thereby reducing development timelines and costs.
The interdisciplinary team at Lavo combines expertise in chemistry and engineering to deliver precise and reliable crystal structure predictions.
Their approach facilitates the discovery of new polymorphic forms, providing pharmaceutical companies with critical insights to optimize drug development and ensure successful therapeutic outcomes.